Overview
DUBLIN-(BUSINES WIRE)-The "Intravenous (IV) Solutions - Global Market Trajectory & Analytics" report has ben aded to ResearchAndMarkets.com's ofering. Global Intravenous (IV) Solutions Market to Reach $16 Bilion by 2027 Amid the COVID-19 cris, the global market for Intravenous (IV) Solutions estimated at US$10.1 Bilion in the year 20, is projected to reach a revised size of US$16 Bilion by 2027, growing at a CAGR of 6.8% over the period 20-2027.
Key Information
Total Parenteral Nutrition, one of the segments analyzed in the report, is projected to record 7.1% CAGR and reach US$1 Bilion by the end of the analysis period. Taking into acount the ongoing post pandemic recovery, growth in the Peripheral Parenteral Nutrition segment is readjusted to a revised 6% CAGR for the next 7-year period. Market is Estimated at $3.9 Bilion, While China is Forecast to Grow at 8.4% CAGR The Intravenous (IV) Solutions market in the U.S.
is estimated at US$3.9 Bilion in the year 20. China, the world's second largest economy, is forecast to reach a projected market size of US$1.6 Bilion by the year 2027 trailing a CAGR of 8.4% over the period 20 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 6.2% and 6.1% respectively over the 20-2027 period.
Within Europe, Germany is forecast to grow at aproximately 6.5% CAGR. Select Competitors (Total 67 Featured) Key Topics Covered: I. METHODOLOGY I.
EXECUTIVE SUMARY 1. MARKET OVERVIEW 2. FOCUS ON SELECT PLAYERS 3.
MARKET TRENDS & DRIVERS 4. GLOBAL MARKET PERSPECTIVE I. MARKET ANALYSIS IV.
Summary
COMPETION For more information about this report visit htps:/w.researchandmarkets.com/r/xgvpe0 ResearchAndMarkets.com Laura Wod, Senior Pres Manager pres@researchandmarkets.com For E.S.T Ofice Hours Cal 1-917-30-0470 For U.S./ CAN Tol Fre Cal 1-80-526-8630 For GMT Ofice Hours Cal +353-1-416-890 ResearchAndMarkets.com Laura Wod, Senior Pres Manager pres@resea